Nuvectis Pharma Q4 EPS $(0.31), Inline
Nuvectis Pharma, Inc. -1.76% Post
Nuvectis Pharma, Inc. NVCT | 8.35 8.35 | -1.76% 0.00% Post |
Nuvectis Pharma (NASDAQ:
NVCT) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. This is a 13.89 percent increase over losses of $(0.36) per share from the same period last year.
